Cell transplantation therapy in acute MI
This article has no abstract so we have provided the first paragraph of the full text.
Therapy with adult progenitor cells has resulted in improved cardiac function after AMI in animal models. The TOPCARE-AMI trial was a pilot study investigating the safety and feasibility of this approach in humans, and providing information for the design of double-blind controlled trials. The final results of the study have recently been published.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
